RNA extraction

RNA Extraction and Purification Kits, Reagents and Instruments Markets, 2035 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 28, 2022

The "RNA Extraction and Purification Kits, Reagents and Instruments Market" report features an extensive study of the current landscape and the likely future potential of RNA extraction and purification kits, reagents and instruments, over the next decade.

Key Points: 
  • The "RNA Extraction and Purification Kits, Reagents and Instruments Market" report features an extensive study of the current landscape and the likely future potential of RNA extraction and purification kits, reagents and instruments, over the next decade.
  • Presently, more than 700 RNA extraction and purification kits and over 180 RNA extraction and purification instruments are available in the market.
  • In order to overcome these drawbacks, extensive research is being carried out to identify/develop ways to improve the RNA extraction and RNA purification kits and instruments.
  • In fact, over 2,300 patents related to RNA extraction and RNA purification have been filed/granted in the past few years.

DNA Extraction Kit Market - Global Outlook & Forecast 2022-2027 - Opportunities in the Availability of Next-Generation DNA Extraction Kits - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 26, 2022

The "DNA Extraction Kit Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "DNA Extraction Kit Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • After the post introduction of DNA extraction kits, the process is simplified and can be carried out efficiently.
  • DNA extraction kit for a tissue sample, DNA extraction kit for forensic DNA, Cell-Free DNA extraction kits, and more.
  • These are major contributors to the DNA extraction kit market by sample type in the market.

Mawi DNA Technologies Announces Partnership with FUJIFILM

Retrieved on: 
Monday, October 4, 2021

Mawi DNA Technologies (Mawi) has signed a distribution agreement with FUJIFILM Wako Pure Chemical Corporation, a leader in the biomedical industry, to deliver Mawis iSWAB biosampling technologies to Japan.

Key Points: 
  • Mawi DNA Technologies (Mawi) has signed a distribution agreement with FUJIFILM Wako Pure Chemical Corporation, a leader in the biomedical industry, to deliver Mawis iSWAB biosampling technologies to Japan.
  • FUJIFILM will be an authorized agent and distributor for Mawi products in Japan to detect viruses such as COVID-19.
  • Mawi DNA Technologies, founded in 2013, has developed and commercialized the iSWAB technology, an innovative system for collection of biosamples.
  • The companys flagship product iSWAB-DNA is the only sample collection product on the market proven to produce a high quality DNA sample with low bacterial DNA content.

MagBio Genomics Inc. Develops Automated RNA Purification Chemistry for Mawi iSWAB-RNA v2 on Thermofisher KingFisher™ Flex

Retrieved on: 
Tuesday, May 11, 2021

It enables up to four weeks of real-time ambient stabilization of total RNA from the point of collection to processing.

Key Points: 
  • It enables up to four weeks of real-time ambient stabilization of total RNA from the point of collection to processing.
  • The MagBio HighPrep Total RNA Plus Kit-iSWAB\xe2\x84\xa2 simplifies this research step, which can be labor-intensive.\n\xe2\x80\x9cMagBio has successfully developed and optimized the HighPrep\xe2\x84\xa2 Total RNA Isolation Kit-iSWAB\xe2\x84\xa2 for extraction of total RNA from iSWAB-RNA v2 samples on Thermofisher KingFisher\xe2\x84\xa2 Flex Purification System,\xe2\x80\x9d said Dr. Mothomang Mlalazi-Oyinloye, Associate Scientific Director, MagBio Genomics.
  • \xe2\x80\x9cThis new method is being used by a major pharmaceutical company to process iSWAB-RNA v2 samples for elucidation of molecular mechanisms of cancer development.
  • We developed an automated method for simplifying RNA purification from iSWAB-RNA v2 samples using our HighPrep\xe2\x84\xa2 Total RNA Plus Kit-iSWAB\xe2\x84\xa2,\xe2\x80\x9d said Dr. Hyacinth Ntchobo, CEO, MagBio Genomics.

Magnostics is Co-Developing and Launching a Viral RNA Extraction Kit for Medium Throughput Processing of COVID-19 Samples for Detection Using RT-PCR

Retrieved on: 
Thursday, November 5, 2020

Magnostics is leading a consortium of University and National Researchers to develop and launch Viral RNA Extraction Kits for detection of COVID-19.

Key Points: 
  • Magnostics is leading a consortium of University and National Researchers to develop and launch Viral RNA Extraction Kits for detection of COVID-19.
  • High rates of testing across the world are key in enabling us to safely navigate our way out of the pandemic.
  • This important demonstration forms the basis for Magnostics Ltd to develop a CE marked 'lab-in-box' kit for the medium throughput manual extraction of viral RNA from clinical samples.
  • Our magnetic nanomaterials are essential components that are used in-vitro diagnostics (IVD), bioseparation, and high throughput screening (HTS).

PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020

Retrieved on: 
Monday, October 12, 2020

Demand for the Companys RT-PCR, RNA extraction systems and kits, and automated liquid handling instrumentation remained robust.

Key Points: 
  • Demand for the Companys RT-PCR, RNA extraction systems and kits, and automated liquid handling instrumentation remained robust.
  • In total, COVID-19 related solutions contributed approximately $280 million of revenue in the third quarter.
  • PerkinElmer will release its third quarter 2020 financial results after market close on Wednesday, October 28, 2020.
  • To access the call, please dial (720) 405-2250 prior to the scheduled conference call time and provide the access code 6884834.

PHASE Scientific Announces CE Mark Approval for the PHASIFY(TM) VIRAL RNA Extraction Kit

Retrieved on: 
Monday, July 20, 2020

GARDEN GROVE, Calif., July 20, 2020 /PRNewswire/ -- PHASE Scientific, a fast-growing biotechnology company, announces today it has received the Conformit Europene (CE)Mark approval for its PHASIFY VIRAL RNA Extraction Kit.

Key Points: 
  • GARDEN GROVE, Calif., July 20, 2020 /PRNewswire/ -- PHASE Scientific, a fast-growing biotechnology company, announces today it has received the Conformit Europene (CE)Mark approval for its PHASIFY VIRAL RNA Extraction Kit.
  • The CE marking confirms that PHASIFY VIRAL complies with the European In-Vitro Diagnostic Devices Directive (98/79/EC), which enables PHASE Scientific to expand commercialization of PHASIFY VIRAL to the European Union and other CE Mark geographies as part of the fight against COVID-19.
  • The PHASIFY VIRAL RNA Extraction Kit is designed to purify and concentrate viral RNA in patient viral transport media samples, and is intended as part of global efforts in detecting and controlling the COVID-19 disease.
  • "Utilizing PHASIFY VIRAL RNA extraction can result in 15-30-fold greater amount of viral RNA for standard RT-qPCR analyses," says Klausner.

PHASE Scientific launches PHASIFY™, a VIRAL RNA Extraction Kit for COVID-19 test

Retrieved on: 
Thursday, April 9, 2020

GARDEN GROVE, Calif., April 9, 2020 /PRNewswire/ --PHASE Scientific announces the worldwide commercial launch of the PHASIFY VIRAL RNA Extraction Kit as part of its global effort to help detect and control the COVID-19 disease.

Key Points: 
  • GARDEN GROVE, Calif., April 9, 2020 /PRNewswire/ --PHASE Scientific announces the worldwide commercial launch of the PHASIFY VIRAL RNA Extraction Kit as part of its global effort to help detect and control the COVID-19 disease.
  • PHASIFY VIRAL purifies and concentrates viral RNA in patient viral transport media samples.
  • PHASIFY VIRAL kit, which incorporates the PHASIFY proprietary liquid phase extraction technology, produces greater viral RNA yields.
  • As proven by validation data, the PHASIFY VIRAL RNA extraction kit enables a 3-6 cycle threshold reduction compared to solid phase extraction.

Zymo Research Announces Partnership with Tecan for COVID-19 Viral RNA Extraction

Retrieved on: 
Wednesday, April 1, 2020

The DreamPrep NAP workstation, featuring Zymo Research's Quick-DNA/RNA Viral MagBead Kit, simplifies the process by providing pre-loaded scripts, optimized for viral RNA extraction, that are currently being validated for COVID-19 assays by high complexity testing labs.

Key Points: 
  • The DreamPrep NAP workstation, featuring Zymo Research's Quick-DNA/RNA Viral MagBead Kit, simplifies the process by providing pre-loaded scripts, optimized for viral RNA extraction, that are currently being validated for COVID-19 assays by high complexity testing labs.
  • Both Zymo Research and Tecan are giving the highest priority to assist researchers who are extracting viral RNA using the DreamPrep NAP workstation."
  • In the past year, Zymo Research and Tecan have worked together to optimize magnetic bead-based extraction of viral RNA using the cutting-edge DreamPrep NAP workstation.
  • The result of this collaboration is a preprogrammed, preconfigured, load-and-go system that is optimized for high-throughput viral RNA extraction.

DNA/RNA Purification Market 2020: New Life Science Dashboards™ From Percepta Project Unit Growth in the Dynamic $1.6 Billion Research Market in North America and Europe

Retrieved on: 
Thursday, March 5, 2020

Today Percepta Associates released its 2020 DNA Purification, Series 1, Life Science Dashboard and 2020 RNA Purification, Series 1, Life Science Dashboard reports.

Key Points: 
  • Today Percepta Associates released its 2020 DNA Purification, Series 1, Life Science Dashboard and 2020 RNA Purification, Series 1, Life Science Dashboard reports.
  • 2020 reports see the addition of several new granular research product segments including cell-free DNA and RNA extraction.
  • This leadership position is entrenched in 9 of the 10 segments surveyed in the DNA purification market and in 3 of the 8 RNA purification segments surveyed.
  • Life Science Dashboards provide rapid access to actionable key market indicators for the DNA and RNA purification markets, in an 'at a glance' easy to understand format.